Treatment of chronic lymphocytic leukemia – a difficult choice for severe complications: a case report

Abstract

University of Medicine and Pharmacy of Targu MuresBackground. Chronic lymphocytic leukemia (CLL) is the most common form of adult leukemia in the western European countries and is characterized by the relentless accumulation of monoclonal B cells with the appearance of small mature lymphocytes and with a characteristic immunophenotype. Even with the right treatment, this disease is known to have a variable course: some patients die within one year after diagnosis while others live for longer than ten years

    Similar works